BioVie (NASDAQ: BIVI)
BioVie Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
BioVie Company Info
BioVie, Inc. is a biopharmaceutical company, which engages in discovery, development, and marketing drug therapies for liver disease. The company was founded on April 10, 2013 and is headquartered in Carson City, NV.
News & Analysis
Why Shares of BioVie Jumped This Week
BioVie's announcement regarding a phase 2 trial for its lead therapy helped raise the stock's price.
Why Shares of BioVie Jumped 51.7% in February
The company is forging ahead with a phase 3 trial for its lead therapy.
Why Shares of BioVie Rose 15.3% in December
The biotech announced positive news from a pair of phase 2 clinical trials.
Why BioVie Stock Is Soaring Today
The more investors learned about BioVie's latest clinical results, the more they liked.
Why BioVie's Shares Tumbled Tuesday
The clinical-stage biotech released data on its prospective Alzheimer's therapy.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.